Vertaling van "about the available educational " (Nederlands → Frans) :

“In the face of this devastating chronic and progressive disease, it is important for AD caregivers to know about the available educational resources, support networks and treatments in order to enhance these discussions at all stages of the disease”.
“In the face of this devastating chronic and progressive disease, it is important for AD caregivers to know about the available educational resources, support networks and treatments in order to enhance these discussions at all stages of the disease ”.

“STRESSLESS – Improving Educators’ Resilience to Stress”: Results available 09-11-2012
“STRESSLESS – Improving Educators’ Resilience to Stress”: Results available 09/11/2012

This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.

The Superior Health Council takes due note of the fact that the European Authorities have made available re-assuring data about the innocuousness of two of the main ingredients of energy drinks, namely taurine and D-glucuronolactone.
Le Conseil Supérieur de la Santé prend acte de la mise à disposition par les autorités européennes de données rassurantes sur l’innocuité de deux principaux composants des boissons énergisantes, à savoir la taurine et la D-glucuronolactone.

With even less input about the callers available than is the case for telephone conversations (there is no way of either seeing or hearing them), the emotional distance between the two persons concerned is even greater and the risk of misunderstanding higher.
Comme on a encore moins d’input sur l’appelant que par téléphone (on ne peut ni le voir ni l’entendre), la distance entre les deux personnes est plus grande sur le plan sentimental et la possibilité de mauvaises interprétations est plus grande.

To learn more about our commitments, please visit us at www.pfizer.com. More information is available at www.pfizer.com.
To learn more about our commitments, please visit us at www.pfizer.com .More information is available at www.pfizer.com.

Written procedures about the precautions to be taken during visits and/or examinations carried out on patients carrying MRSA must be available.
Des procédures écrites concernant les précautions à prendre au cours des visites et/ou des examens effectués sur des patients porteurs de MRSA doivent être disponibles.

Information about sample availability e-mail ech_staal@fagg-afmps.be
Information about sample availability e-mail ech_staal@fagg-afmps.be

EU - Publication about Active Ageing available in all EU official languages 15-11-2012
EU - Publication about Active Ageing available in all EU official languages 15/11/2012